Morphological Determinants of Femoral Strength in Growth Hormone-Deficient Transgenic Growth-Retarded (Tgr) Rats
Open Access
- 1 July 2003
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 18 (7) , 1308-1316
- https://doi.org/10.1359/jbmr.2003.18.7.1308
Abstract
The extent to which childhood GHD affects adult fracture risk is unclear. We measured femoral strength in adult transgenic growth-retarded rats as a model of GHD. Long-term, moderate GHD was accompanied by endocrine and morphometric changes consistent with a significant reduction in femoral strength. Childhood growth hormone deficiency (GHD) is associated with osteopenia, but little is known about its effects on subsequent adult bone strength and fracture risk. We have therefore measured femoral strength (failure load measured by three-point bending) in a new model of moderate GHD, the transgenic growth-retarded (Tgr) rat at 15, 22-23, and 52 weeks of age, and have quantified potential morphological and endocrine determinants of bone strength. Skeletal growth retardation in Tgr rats was accompanied by a sustained reduction in the anterior-posterior diameter of the femoral cortex, whereas mid-diaphyseal cortical wall thicknesses were largely unaltered. Total femoral strength was significantly impaired in Tgr rats (p < 0.01), and this impairment was more pronounced in males than females. Compromised bone strength in Tgr rats could not be accounted for by the reduction in mechanical load (body weight) and was not caused by impairment of the material properties of the calcified tissue (ultimate tensile stress), despite marked reductions in femoral mineral density (areal bone mineral density; p < 0.001). Microcomputerized tomographical analysis revealed significant modification of the architecture of trabecular bone in Tgr rats, with reductions in the number and thickness of trabeculae (p < 0.05) and in the degree of anisotropy (p < 0.01). The marked reduction in plasma insulin-like growth factor-1 in Tgr rats was accompanied by the development of high circulating leptin levels (p < 0.01). These results show that the changes in endocrinology and bone morphology associated with long-term moderate GHD in Tgr rats are accompanied by changes consistent with a significant reduction in the threshold for femoral fracture.Keywords
This publication has 36 references indexed in Scilit:
- Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research SocietyJournal of Pediatric Endocrinology and Metabolism, 2001
- Bone Markers and Bone Mineral Density during Growth Hormone Treatment in Children with Growth Hormone DeficiencyHormone Research in Paediatrics, 2000
- Growth Hormone and BoneEndocrine Reviews, 1998
- A new method for the model‐independent assessment of thickness in three‐dimensional imagesJournal of Microscopy, 1997
- Growth hormone stimulates bone formation and strength of cortical bone in aged ratsJournal of Bone and Mineral Research, 1995
- Effect of growth hormone on bone: Bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormoneJournal of Bone and Mineral Research, 1995
- A 20-Year Perspective on the Mechanical Properties of Trabecular BoneJournal of Biomechanical Engineering, 1993
- The GH-Transgenic Mouse as an Experimental Model for Growth Research: Clinical and Pathological StudiesHormone Research, 1992
- Growth Hormone and BoneHormone Research, 1991
- Bone mineral status in growth hormone deficiencyThe Journal of Pediatrics, 1980